NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM7696967 Query DataSets for GSM7696967
Status Public on Mar 31, 2024
Title Rv1_WT_Int_SNX631_Rep5
Sample type SRA
 
Source name xenograft
Organism Homo sapiens
Characteristics tissue: xenograft
cell line: 22Rv1
cell type: prostate cancer cells
genotype: WT
treatment: Rv1-WT xenograft (WT_Int_Snx_#3) growing intact NSG male mice, SNX631 treatment group (Int-Snx)
Treatment protocol For SNX631 in vivo treatment, animals were randomly allocated to two study groups when the mean tumor size reached 100-200 mm^3. For Rv1-WT study, the treatment group received SNX631-medicated diet (500 ppm, producing 30-60 mg/kg/day dosage on average) and the control group received the control diet. For Rv1-Luc study, the animals in the control group were dosed with vehicle (70% PEG-400/30% Propylene Glycol, 5 mL/kg, p.o., b.i.d.) and the treatment group was dosed with SNX631 (6 mg/mL solution in the vehicle, 5 mL/kg, p.o., b.i.d.) at 60 mg/kg/day.
Growth protocol 22Rv1 and its derivatives were cultured in RPMI-1640 media supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate, 1.5 g/L sodium bicarbonate, 10 mM HEPES, 0.45% D-glucose, and either 10% fetal bovine serum (FBS) or charcoal stripped FBS (CSS), plus 1% penicillin-streptomycin (P/S). Cells were inoculated s.c. (2x10^6 cells in 0.1 mL 50% Matrigel per animal) in the right flank of intact or castrated male NSG mice to form xenograft tumors
Extracted molecule total RNA
Extraction protocol Tumor tissues were first submerged in 500 μL RNA-Later stabilization solution (Thermo Fisher Scientific) at room temperature. After stabilization, RNA samples were extracted from tumor tissues using the mRNeasy Mini Kit (QIAGEN) according to the manufacturer’s protocol. RNA quality was validated on RNA-1000 chip using Bioanalyzer (Agilent)
Sequencing libraries were generated using NEBNext Ultra II Directional RNA Library prep Kit
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 4000
 
Data processing Indexed sequences were checked quality by Fastqc
Indexed sequences were trimmed adaptor sequence by cutadapt (v 2.8) with parameters -m 75 -q 30
Reads were aligned to a hybrid reference genome consisting of both the human GRCh38.p13 primary assembly genome and the mouse GRCm39 primary assembly genome, utilizing STAR (v 2.7.2b) with parameter --outFilterMismatchNoverReadLmax 0.01 --outFilterMultimapNmax 1
Read counts over annotated genes were obtained using featureCount (subreads | version: 2.0.3) with parameters -T 12 -B -O --fraction -s 2 -p --countReadPairs -d 50 -D 800 -g gene_id
Assembly: GRCh38.p13 & GRCm39
Supplementary files format and content: tab-delimited text files include human and mouse gene counts for each sample
 
Submission date Aug 08, 2023
Last update date Mar 31, 2024
Contact name HAO JI
E-mail(s) ji5@email.sc.edu
Phone 8037774689
Organization name University of South Carolina
Department College of Pharmacy
Street address 715 SUMTER ST CLS RM 109
City COLUMBIA
State/province SC
ZIP/Postal code 29208
Country USA
 
Platform ID GPL20301
Series (1)
GSE240370 Transcriptomic analysis of the in vivo effects of CDK8/19 inactivation in 22Rv1 xenografts growing in intact and castrated NSG mice
Relations
BioSample SAMN36891840
SRA SRX21300845

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap